Vimarsana
Biggest News Aggregation in the World

Page 4 - Clinical Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Sciences Today - Breaking & Trending Today

Researcher discovers that endometriosis tricks the immune system in the same way cancer does - Vimarsana News

Researcher discovers that endometriosis tricks the immune system in the same way cancer does

Treatment options for those suffering from endometriosis are currently few, but research at Umeå University provides new opportunities to understand the disease. A new thesis answers the question of how cells, which are normally found inside the uterus, can gain a foothold in the abdomen and evade the immune system. The results can hopefully contribute to new treatments.

Social Factors May Lower Heart Disease Risk by Gender - Vimarsana News

Social Factors May Lower Heart Disease Risk by Gender

Differences in social factors that may reduce cardiovascular disease (CVD) risk for men and women have been identified by Monash University-led

Researchers Find Shared Multiomic Molecular Dysregulations in Brains With PTSD and MDD - Vimarsana News

Researchers Find Shared Multiomic Molecular Dysregulations in Brains With PTSD and MDD

The investigators are optimistic that the data can establish stress-related pathways while revealing potential therapeutic options for patients with major depressive disorder and post-traumatic stress disorder.

UNILORIN student expelled over alleged ransom demand on missing colleague - Vimarsana News

UNILORIN student expelled over alleged ransom demand on missing colleague

The authorities of the University of Ilorin in Kwara State have expelled a 100-Level student of the institution, Olanrewaju AbdulKadir, for allegedly demanding a ransom from the parent of his missing colleague.

Trastuzumab Deruxtecan Prolongs PFS in Pretreated HR+, HER2-Low and -Ultralow Metastatic Breast Cancer - Vimarsana News

Trastuzumab Deruxtecan Prolongs PFS in Pretreated HR+, HER2-Low and -Ultralow Metastatic Breast Cancer

Trastuzumab deruxtecan improved PFS vs chemotherapy in pretreated, HR-positive, HER2-low or -ultralow metastatic breast cancer.